FindTrial
Sign In

Mutations in the SPDYA gene can lead to impaired spermatogenesis

Research on the Function of SPDYA Gene in Spermatogenesis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094698
Enrollment
Unknown
Registered
2024-12-26
Start date
2025-01-02
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-obstructive azoospermia

Interventions

case group (NOA ):None
A family with one case of non-obstructive azoospermia with SPDYA mutation:None
control group (Normal spermatogenic function):None

Sponsors

Women's Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1 case of non-obstructive azoospermia (NOA) patient with SPDYA mutation from a consanguineous family, including his sister and parents; Patients with non obstructive azoospermia and normal spermatogenic function

Exclusion criteria

Exclusion criteria: Patients with a history of malignant tumors, organ transplantation, and radiotherapy or chemotherapy, as well as NOA patients whose cause of disease has already been identified.

Design outcomes

Primary

MeasureTime frame
SPDYA gene mutation;—

Countries

China

Contacts

Public ContactJingping Li

Women's Hospital, School of Medicine, Zhejiang University

lijingpingself@zju.edu.cn+86 18667128816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026